期刊文献+

六君子丸联合四联疗法提高脾胃虚弱型Hp感染者根除率的研究 被引量:1

Six Gentlemen pill combined with quadruple therapy to improve the rate oferadication of spleen and stomach type Hp infection
下载PDF
导出
摘要 目的探究六君子丸联合四联疗法治疗脾胃虚弱型幽门螺旋杆菌(Hp)感染者的临床效果。方法选取2010年8月—2013年5月在我院就诊的600例因Hp感染引发消化性溃疡的患者,其中脾胃虚弱型Hp感染者72例,将其随机分为对照组和观察组,每组36例。对照组采用四联疗法,观察组在此基础上加用六君子丸,观察比较两组患者的治疗效果及Hp根除率。结果对照组总有效率为88.9%,观察组总有效率为91.7%,两组的总有效率差异无统计学意义(P>0.05);对照组患者Hp根除率为66.7%,观察组患者Hp根除率为83.3%。观察组Hp根除率明显高于对照组,具有统计学意义(P<0.05)。结论采用六君子丸联合四联疗法能够显著提高脾胃虚弱型Hp感染者的根除率,值得临床借鉴使用。 Objective To explore the Six Gentlemen pill combined with quadruple therapy treatment weakness of spleen and stomach Helicobacter pylori(Hp) infection the clinical effect. Methods From 2010 August to 2013 May in our hospital 600 cases of patients with Hp infection caused by peptic ulcer, the weakness of spleen and stomach of Hp infection in 72 cases, which were randomly divided into control group and observation group, each group of 36 cases. The control group using quadruple therapy,observation group based on the use of Six Gentlemen pill, to observe the therapeutic effect of two groups were compared and the Hp eradication rate. Results The control group the total effective rate was 88.9%, total effective rate of observation group was91.7%, the effective rates of two groups had no significant difference(P〉0.05); the control group of patients with Hp eradication rate was 66.7%,the observation group of patients with Hp eradication rate was 83.3%. The observation group Hp eradication rate was significantly higher than the control group, with statistical significance(P〈0.05).Conclusion The Six Gentlemen pill combined with quadruple therapy can significantly improve the eradication rate of spleen and stomach type Hp infection, worthy of clinical use.
出处 《中国卫生产业》 2014年第29期44-45,共2页 China Health Industry
关键词 六君子丸 四联疗法 脾胃虚弱型 HP感染 Six Gentlemen pill Quadruple therapy The wealcness of spleen and stmach type Hpinfection
  • 相关文献

参考文献6

二级参考文献27

  • 1胡伏莲.重视幽门螺杆菌耐药菌株的研究[J].胃肠病学,2006,11(7):385-387. 被引量:30
  • 2朱琦,刘文忠.幽门螺杆菌感染处理的当代概念Maastricht Ⅲ共识报告[J].中华消化杂志,2007,27(4):257-261. 被引量:49
  • 3Chen JH, Kim N, Lee DH, et al. Trial of moxifloxacin-containing triple therapy after initial and second -line treatment failures for Helieobaeter pylori infection [ J ]. Korean J Gastroenterol, 2005,45 (2) :111-117.
  • 4Lee JH, Shin JH, Roe IH, ct al. Impact of clarithromycin resistance on eradication of Helicobacter pylori in infected adults[ J]. Antimicrob Agents Chemother, 2005,49 (4) :1600-1603.
  • 5Fischbach L, Evans EL. Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori[ J]. Aliment Pharmacol Ther, 2007,26 (3) : 343-357.
  • 6Montes Teves P,Salazar Ventura S,Monge Salgado E.Epidemiological changes in peptic ulcer and their relation with Helicobacter pylori.Hospital Daniel A Carrion 2000-2005.Rev Gastroenterol Peru,2007,27(4):382-388.
  • 7Ford AC,Delaney BC,Forman D,et al.Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients.Cochrane Database Syst Rev,2006,19(2):CD003840.
  • 8De Francesco V,Margiotta M,Zullo AJ,et al.Prevalence of primary clarithromycin resistance in Helicobacter pylori strains over a 15 year period in Italy.J Antimicrob Chemother,2007,59(4):783-785.
  • 9成虹,胡伏莲,谢勇,胡品津,王吉耀,吕农华,张建中,张桂英,周曾芬,吴克利,张玲霞,彭孝伟,戴宁,唐国都,姜葵,李岩,侯晓华,白文元,王明春,叶红军,刘玉兰,许乐.中国幽门螺杆菌耐药状况以及耐药对治疗的影响—全国多中心临床研究[J].胃肠病学,2007,12(9):525-530. 被引量:518
  • 10Li X Q, Andersson T B, Ahlstrm M, et al.Comparison of inhibitory effects of the proton pump-inhibiting drugs o- meprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities [J]. Drug Metab Dispos, 2004,32(8):821-827.

共引文献75

同被引文献11

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部